Utility Therapeutics Secures US FDA Nod To Treat Urinary Tract Infections

Utility Therapeutics Ltd has received FDA approval for Pivya (pivmecillinam) tablets to treat female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible strains of Escherichia coli, Proteus mirabilis, and...

ImmunityBio Bags US FDA Nod For Anktiva to treat Patient with Bladder Cancer

ImmunityBio, Inc, a biotechnology firm, declared that Anktiva (N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) is now approved by the US Food and Drug Administration for the treatment of patients with BCG...

PRISM BioLab Forays into a Joint Research and Licensing Agreement with Ono

PRISM BioLab, a biotechnology firm, is proposing little particle inhibitors of protein-protein interaction (PPI) targets, declared that it has gone into an objective selective exploration and licensing agreement with ONO PHARMACEUTICAL CO...

Sightsavers India Fellowship Program Invites Applications for Promising Ophthalmologists

Sightsavers India, a development organisation dedicated to eliminating avoidable blindness and promoting equality of opportunity for individuals with disabilities, announces the commencement of applications for its annual Fellowship Programme

India's pharma Exports Increase 10% to USD 27.9 Billion in FY24

The nation's drug and pharmaceutical exports rose 9.67 percent year-on-year to USD 27.9 billion in 2023-24, even though total exports decreased by 3% in the previous fiscal year. Pharma exports increased by 12.73 percent to USD 2.8 billion in...

Key Decisionmakers Mark Their Presence At Analytica Anacon India & India Lab Expo 2024 In Mumbai

The recent Mumbai edition of analytica Anacon India and India Lab Expo, organised jointly by Messe Muenchen India and the Indian Analytical Instruments Association (IAIA), concluded successfully with satisfied exhibitors and delighted visitors.

© 2024 India Pharma Outlook. All Rights Reserved.